Comparative study on the incidence of non-COVID-19 viral pneumonia before and after the COVID-19 pandemic: A retrospective analysis based on respiratory non-COVID viral nucleic acid results
- PMID: 39310063
- PMCID: PMC11411423
- DOI: 10.1016/j.jointm.2024.02.005
Comparative study on the incidence of non-COVID-19 viral pneumonia before and after the COVID-19 pandemic: A retrospective analysis based on respiratory non-COVID viral nucleic acid results
Abstract
Background: The impact of the coronavirus disease 2019 (COVID-19) pandemic on the etiology of non-COVID-19 viral pneumonia remains to be identified. We investigated the evolution of non-COVID-19 viral pneumonia in hospitalized patients before and after the COVID-19 pandemic.
Methods: This is a single-center retrospective study. Patients who came to West China Hospital of Sichuan University diagnosed with non-COVID-19 viral pneumonia from January 1, 2016 to December 31, 2021, were included and divided into pre- and post-COVID-19 groups according to the date of the COVID-19 outbreak in China. The results of 13 viral nucleic acid tests were compared between the two groups.
Results: A total of 5937 patients (3954 in the pre-COVID-19 group and 1983 in the post-COVID-19 group) were analyzed. Compared with the pre-COVID-19 group, the proportion of patients tested for respiratory non-COVID-19 viral nucleic acid was significantly increased in the post-COVID-19 group (14.78% vs. 22.79%, P <0.05). However, the non-COVID-19 virus-positive rates decreased from 37.9% to 14.6% after the COVID-19 outbreak (P < 0.001). Notably, non-COVID-19 viral pneumonia caused by the influenza A virus H1N1 (InfAH1N1) (2009) dropped to 0% after the pandemic. The top three viruses were InfAH1N1 (2009) (13.9%), human rhinovirus (7.4%), and human adenovirus (3.4%) in the pre-COVID-19 group, and human rhinovirus (3.8%), human respiratory syncytial virus (2.0%), human parainfluenza virus (1.1%) and InfAH3N2 (1.1%) in the post-COVID-19 group.
Conclusions: The proportion of non-COVID-19 viral pneumonia decreased significantly after the COVID-19 outbreak, among which InfAH1N1 (2009) pneumonia decreased the most dramatically.
Keywords: COVID-19; Influenza virus, H1N1; Virus nucleic acid.
© 2024 The Authors.
Figures



Similar articles
-
Viral Pneumonia during the COVID-19 Pandemic, 2019-2021 Evoking Needs for SARS-CoV-2 and Additional Vaccinations.Vaccines (Basel). 2023 Apr 27;11(5):905. doi: 10.3390/vaccines11050905. Vaccines (Basel). 2023. PMID: 37243009 Free PMC article.
-
Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.Lancet Microbe. 2023 May;4(5):e340-e348. doi: 10.1016/S2666-5247(22)00386-X. Epub 2023 Mar 22. Lancet Microbe. 2023. PMID: 36965504 Free PMC article.
-
Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.Mil Med Res. 2021 Feb 16;8(1):13. doi: 10.1186/s40779-021-00306-7. Mil Med Res. 2021. PMID: 33593415 Free PMC article.
-
Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children.BMC Pediatr. 2024 Feb 2;24(1):91. doi: 10.1186/s12887-024-04566-9. BMC Pediatr. 2024. PMID: 38302912 Free PMC article. Review.
-
Recent advances in the detection of respiratory virus infection in humans.J Med Virol. 2020 Apr;92(4):408-417. doi: 10.1002/jmv.25674. Epub 2020 Feb 4. J Med Virol. 2020. PMID: 31944312 Free PMC article. Review.
Cited by
-
Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients.Medicina (Kaunas). 2025 Jul 10;61(7):1251. doi: 10.3390/medicina61071251. Medicina (Kaunas). 2025. PMID: 40731880 Free PMC article.
References
-
- Varela F.H., Scotta M.C., Polese-Bonatto M., Sartor I.T.S., Ferreira C.F., Fernandes I.R., et al. Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community. J Glob Health. 2021;11:05007. doi: 10.7189/jogh.11.05007. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources